Sunfa Cheng Selected Research

erenumab

1/2023	Long-term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysis.
1/2023	Long-term efficacy and safety of erenumab in Japanese patients with episodic and chronic migraine: results from a 28-week open-label treatment period of a randomised trial.
1/2022	Early onset of efficacy with erenumab for migraine prevention in Japanese patients: Analysis of two randomized, double-blind, placebo-controlled studies.
1/2022	Long-term efficacy and safety of erenumab in patients with chronic migraine in whom prior preventive treatments had failed: A subgroup analysis.
10/2021	Efficacy of erenumab in chronic migraine patients with and without ictal allodynia.
9/2021	Efficacy and safety of erenumab in Japanese migraine patients with prior preventive treatment failure or concomitant preventive treatment: subgroup analyses of a phase 3, randomized trial.
7/2021	Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trials.
4/2021	Long-term efficacy and safety during open-label erenumab treatment in Japanese patients with episodic migraine.
1/2021	Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a post-hoc analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extension.
1/2021	Erenumab treatment for migraine prevention in Japanese patients: Efficacy and safety results from a Phase 3, randomized, double-blind, placebo-controlled study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sunfa Cheng Research Topics

Disease

21	Migraine Disorders (Migraine) 01/2023 - 09/2017
5	Headache (Headaches) 07/2021 - 09/2017
3	Secondary Hyperparathyroidism 11/2021 - 10/2017
3	Heart Failure 01/2018 - 10/2012
3	Primary Hyperparathyroidism 01/2011 - 08/2009
2	Prescription Drug Overuse 01/2023 - 01/2019
2	Chronic Renal Insufficiency 11/2021 - 10/2020
2	Nasopharyngitis 01/2021 - 11/2019
2	Hypercalcemia (Milk Alkali Syndrome) 01/2011 - 08/2009
2	Neoplasm Metastasis (Metastasis) 07/2010 - 09/2002
1	Pain (Aches) 01/2023
1	Hyperalgesia 10/2021
1	Secondary Headache Disorders 07/2021
1	Constipation 01/2021
1	Back Pain (Backache) 01/2021
1	Hypertension (High Blood Pressure) 01/2020
1	Systolic Heart Failure 03/2013
1	Stroke (Strokes) 03/2013
1	Anemia 03/2013
1	Breast Neoplasms (Breast Cancer) 07/2010
1	Ischemia 10/2006
1	Reperfusion Injury 10/2006
1	Fibrosis (Cirrhosis) 06/2003
1	Cardiomyopathies (Cardiomyopathy) 02/2003

Drug/Important Bio-Agent (IBA)

21	erenumabIBA 01/2023 - 09/2017
5	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 01/2021 - 09/2017
4	Cinacalcet (Sensipar)FDA Link 10/2017 - 08/2009
3	etelcalcetide hydrochlorideIBA 11/2021 - 10/2017
3	Monoclonal AntibodiesIBA 01/2021 - 01/2019
3	Darbepoetin alfa (Aranesp)FDA Link 01/2018 - 03/2013
3	CalciumIBA 01/2011 - 08/2009
3	Matrix Metalloproteinase 2 (Gelatinase A)IBA 10/2006 - 09/2002
2	Tryptamines (Triptans)IBA 10/2021 - 07/2021
2	Parathyroid Hormone (Parathormone)IBA 10/2020 - 10/2017
2	Hemoglobins (Hemoglobin)IBA 03/2013 - 10/2012
2	Matrix Metalloproteinase 14 (MT1-MMP)IBA 07/2010 - 06/2003
2	Matrix Metalloproteinases (MMPs)IBA 07/2010 - 02/2003
2	Proteins (Proteins, Gene)FDA Link 10/2006 - 09/2002
1	pro-brain natriuretic peptide (1-76)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 10/2006
1	Y-Box-Binding Protein 1IBA 09/2002
1	Trans-Activators (Trans-Acting Factor)IBA 09/2002

Therapy/Procedure

3	Therapeutics 01/2023 - 11/2019
3	Renal Dialysis (Hemodialysis) 11/2021 - 10/2017
1	Subcutaneous Injections 11/2019
1	Contraindications 08/2009
1	Parathyroidectomy 08/2009